Register Now for the Free Fall Physician Bootcamp
The Medical Economics® Fall Physician Bootcamp program provides beyond-the-classroom business training for physicians.
Primary Care Clinician-Patient Face Time Trending Down, Treatment Inequities Continue to Rise
US face time with primary care clinicians has decreased by 10% since 2005 along with number of visits. A new study looks closely at trends in the physician-patient encounter.
DASH Diet May Prevent Nearly 27 000 US CVD Events in Patients with Stage 1 Hypertension, According to Simulation Study
AHA Hypertension 2022: Adoption of the DASH diet was found to prevent an estimated 16 000 CVD events among men and 11 000 among women with untreated stage 1 HTN.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 8, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Education on Use of ABPM Data Needed in Primary Care to Avoid Misdiagnosis of Hypertension
AHA Hypertension 2022. Half of patients with newly elevated BP had white coat HTN yet some were diagnosed with HTN at next primary care visit, new study finds.
COVID-19 mRNA Vaccines Found Safe in Patients with Heart Failure in Real-world Study
ESC 2022: SARS-CoV-2 mRNA vaccines were not associated with an increased risk of worsening heart failure, venous thromboembolism, or myocarditis in a large Danish real-world study.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 7, 2022
Hypertension Awareness and Control Improved with Better Access to Primary Care, New Study Finds
Regardless of where individuals live, they may benefit from blood pressure control programs that increase access to primary health care, study authors suggest.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 6, 2022
DASH Diet, Weight Loss, Exercise and Other Nondrug Strategies to Manage Hypertension
Find out how effective these 3 and 5 additional ACC/AHA-recommended non-drug interventions are at reducing BP (in mm Hg) in adults with hypertension and with normal BP.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of September 2, 2022
High HDL-C Increases CV Risk in Men with Hypertension, Study Finds
In patients with hypertension, HDL-C >80 mg/dL was linked to a greater risk for CV events among men but not among women. Protective?
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 31, 2022
Primary Care Month in Review: 6 Popular Stories from August 2022
Use of exercise trackers associated with improved physical activity, FDA recommends repeat at-home COVID-19 antigen testing, and 4 more top content from August.
FDA Authorizes Pfizer and Moderna Updated COVID-19 Booster Shots
The FDA EUA amendments for updated booster vaccinations are based on clinical studies of the omicron BA.1 variant and preclinical data on the BA.4 and BA.5 variants.
Polypill Reduces Risk of MACE in Secondary Prevention for Older Adults: Results from SECURE
Taking a 3-drug polypill (aspirin, ACEi, statin) vs each of the drugs separately reduced risk for a major CV event by 33%, according to results of the SECURE trial.
The Future of US Antimicrobial Resistance is in Our Hands and There is Work to Do
Steer clear of antibiotic Rxs whenever possible, says Anne Meneghetti, MD, to help the US get back to pre-COVID levels of antimicrobial stewardship.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of August 30, 2022
Specific Blood Pressure Thresholds Not Needed When Selecting Patients with T2D for Antihypertensive Treatment, Suggests New Research
Blood pressure-lowering therapy reduced the risk of major CV events in persons with and without type 2 diabetes, according to an individual participant-level data meta-analysis.
8 Key Drivers of Hypertension Control & How to Improve Them
These 8 drivers of BP control reflect study of high-performing health systems and the strategies that have led to successful large scale hypertension management.
